Cargando…

Therapeutic Effects of Melatonin Receptor Agonists on Sleep and Comorbid Disorders

Several melatonin receptors agonists (ramelteon, prolonged-release melatonin, agomelatine and tasimelteon) have recently become available for the treatment of insomnia, depression and circadian rhythms sleep-wake disorders. The efficacy and safety profiles of these compounds in the treatment of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laudon, Moshe, Frydman-Marom, Anat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200764/ https://www.ncbi.nlm.nih.gov/pubmed/25207602 http://dx.doi.org/10.3390/ijms150915924

Ejemplares similares

Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer’s disease: a 6-month, randomized, placebo-controlled, multicenter trial
por: Wade, Alan G, et al.
Publicado: (2014)

Melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, attenuates TNBS-induced colitis in mice
por: Zielińska, Marta, et al.
Publicado: (2016)

Mood Disorders, Circadian Rhythms, Melatonin and Melatonin Agonists
por: Quera Salva, M.A., et al.
Publicado: (2012)

Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials
por: Grossman, Ehud, et al.
Publicado: (2011)

Comparative Review of Approved Melatonin Agonists for the Treatment of Circadian Rhythm Sleep‐Wake Disorders
por: Williams, Wilbur P. (Trey), et al.
Publicado: (2016)

Melatonin and melatonergic drugs in sleep disorders
por: Kim, Hyung Ki, et al.
Publicado: (2022)

The Melatonin Receptor Agonist Ramelteon Effectively Treats Insomnia and Behavioral Symptoms in Autistic Disorder
por: Kawabe, Kentaro, et al.
Publicado: (2014)

Neuroprotective Effect of Melatonin on Sleep Disorders Associated with Parkinson’s Disease
por: Hu, Xinyu, et al.
Publicado: (2023)

Melatonin and Its Agonist Ramelteon in Alzheimer's Disease: Possible Therapeutic Value
por: Srinivasan, Venkatramanujam, et al.
Publicado: (2010)

Prolonged-release melatonin for insomnia – an open-label long-term study of efficacy, safety, and withdrawal
por: Lemoine, Patrick, et al.
Publicado: (2011)

Melatonin and Comorbidities in Children with Autism Spectrum Disorder
por: Gagnon, Katia, et al.
Publicado: (2018)

Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety
por: Wade, Alan G, et al.
Publicado: (2010)

Sleep-promoting action of IIK7, a selective MT(2) melatonin receptor agonist in the rat
por: Fisher, Simon P., et al.
Publicado: (2009)

New MT(2) Melatonin Receptor-Selective Ligands: Agonists and Partial Agonists
por: Boutin, Jean A., et al.
Publicado: (2017)

Protective effects of melatonin receptor agonists on endotoxin-induced uveitis in rats
por: Yuksel, Tugba Nurcan, et al.
Publicado: (2023)

Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study
por: Garfinkel, Doron, et al.
Publicado: (2011)

Traumatic Brain Injury, Sleep, and Melatonin—Intrinsic Changes with Therapeutic Potential
por: Bell, Allen, et al.
Publicado: (2023)

Effect of melatonin in children with neurodevelopmental disabilities and sleep disorders
por: Al Twaijri, Waleed A., et al.
Publicado: (2022)

The genomic response of human granulosa cells (KGN) to melatonin and specific agonists/antagonists to the melatonin receptors
por: Arjoune, Asma, et al.
Publicado: (2022)

Effects of glucagon-like peptide 1 receptor agonists on comorbidities in older patients with diabetes mellitus
por: Onoviran, Olusola F., et al.
Publicado: (2019)

Melatonin Receptors Agonistic Activities of Phenols from Gastrodia elata
por: Chen, Si-Yue, et al.
Publicado: (2019)

Structure-based discovery of potent and selective melatonin receptor agonists
por: Patel, Nilkanth, et al.
Publicado: (2020)

Melatonin as a Chronobiotic/Cytoprotective Agent in REM Sleep Behavior Disorder
por: Cardinali, Daniel P., et al.
Publicado: (2023)

Melatonin and Melatonin Agonists for Prevention of Delirium in the Cardiac Surgical ICU: A Meta-analysis
por: Niyogi, Subhrashis Guha, et al.
Publicado: (2023)

Comorbidities of sleep disorders in childhood and adolescence: focus on migraine
por: Dosi, Claudia, et al.
Publicado: (2013)

Exploring Astrocyte-Mediated Mechanisms in Sleep Disorders and Comorbidity
por: Li, Yujuan, et al.
Publicado: (2023)

The analgesic effect of therapeutic rTMS is not mediated or predicted by comorbid psychiatric or sleep disorders
por: Lindholm, Pauliina, et al.
Publicado: (2016)

Effect of melatonin and melatonin agonists on postoperative sleep quality in adult patients: a protocol for systematic review and meta-analysis with trial sequential analysis
por: Tsukinaga, Akito, et al.
Publicado: (2021)

Melatonin receptor agonists—ramelteon and melatonin—for bipolar disorder: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials
por: Kishi, Taro, et al.
Publicado: (2019)

Study of the Effects of Melatonin on Sleep Disorders in Pulmonary Sarcoidosis Patients
por: Feizabadi, Faezeh, et al.
Publicado: (2023)

The Effects of the Exogenous Melatonin on Shift Work Sleep Disorder in Health Personnel: A Systematic Review
por: Carriedo-Diez, Bárbara, et al.
Publicado: (2022)

Shumian Capsule Improves the Sleep Disorder and Mental Symptoms Through Melatonin Receptors in Sleep-Deprived Mice
por: Li, Wenhua, et al.
Publicado: (2022)

Melatonin as a Potential Adjuvant Treatment for COVID-19 beyond Sleep Disorders
por: Wichniak, Adam, et al.
Publicado: (2021)

Effect of Melatonin Administration on Sleep Quality in Sulfur Mustard Exposed Patients with Sleep Disorders
por: Mousavi, Seyyedeh Soghra, et al.
Publicado: (2018)

Pediatric sleep disturbances and treatment with melatonin
por: Esposito, Susanna, et al.
Publicado: (2019)

How to Assess the Headache—Sleep Disorders Comorbidity in Children and Adolescents
por: Onofri, Agnese, et al.
Publicado: (2021)

Comorbidity and confounding factors in attention-deficit/hyperactivity disorder and sleep disorders in children
por: Jan, Ya-Wen, et al.
Publicado: (2011)

Evaluating the Potential Effect of Melatonin on the post-Cardiac Surgery Sleep Disorder
por: Dianatkhah, Mehrnoush, et al.
Publicado: (2015)

Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults
por: Tuft, Colin, et al.
Publicado: (2023)

Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders
por: Ferracioli-Oda, Eduardo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_mj4170lf43g19km4uqk1cq0q9c